Urinary Equol and Equol‐Predicting Microbial Species Are Favorably Associated With Cardiometabolic Risk Markers in Chinese Adults

Abstract

Background The association between soy isoflavones intake and cardiometabolic health remains inconclusive. We investigated the associations of urinary biomarkers of isoflavones including daidzein, glycitein, genistein, equol (a gut microbial metabolite of daidzein), and equol‐predicting microbial species with cardiometabolic risk markers. Methods and Results In a 1‐year study of 305 Chinese community‐dwelling adults aged ≥18 years, urinary isoflavones, fecal microbiota, blood pressure, blood glucose and lipids, and anthropometric data were measured twice, 1 year apart. Brachial‐ankle pulse wave velocity was also measured after 1 year. A linear mixed‐effects model was used to analyze repeated measurements. Logistic regression was used to calculate the adjusted odds ratio (aOR) and 95% CI for the associations for arterial stiffness. Each 1 μg/g creatinine increase in urinary equol concentrations was associated with 1.47%, 0.96%, and 3.32% decrease in triglycerides, plasma atherogenic index, and metabolic syndrome score, respectively (all P<0.05), and 0.61% increase in high‐density lipoprotein cholesterol (P=0.025). Urinary equol was also associated with lower risk of arterial stiffness (aOR, 0.28 [95% CI, 0.09–0.90]; Ptrend=0.036). We identified 21 bacterial genera whose relative abundance was positively associated with urinary equol (false discovery rate‐corrected P<0.05) and constructed a microbial species score to reflect the overall equol‐predicting capacity. This score (per 1‐point increase) was inversely associated with triglycerides (percentage difference=−1.48%), plasma atherogenic index (percentage difference=−0.85%), and the risk of arterial stiffness (aOR, 0.27 [95% CI, 0.08–0.88]; all P<0.05). Conclusions Our findings suggest that urinary equol and equol‐predicting microbial species may improve cardiometabolic risk parameters in Chinese adults.

Keywords

• cardiometabolic risk
• equol
• gut microbiome
• isoflavones
• repeated measurements